Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Early in the new Netflix miniseries “Apple Cider Vinegar,” the central character of Millie Blake is diagnosed with a rare ...
Aroldis Chapman has been one of baseball's hardest throwers for 16 years while largely avoiding injury. Friday the new Red ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
Hosted on MSN7h
Veterans claim they got cancer while working at Area 51, but DOD denies they were ever thereNewsNation Anchor Natasha Zouves has much more on the Area 51 veterans fighting for benefits. To watch her full report, tune ...
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback